91 results
Page 4 of 5
8-K
EX-99.1
qe5ax4iq
1 Nov 19
Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors
7:35am
S-3
EX-4.4
gx73h3h4fcbeduaw
6 Aug 19
Shelf registration
4:39pm
S-3
mivhpyhb
6 Aug 19
Shelf registration
4:39pm
8-K
EX-99.1
2yzalsl
6 Aug 19
Neuronetics Reports Second Quarter 2019 Financial and Operating Results
7:30am
8-K
hgs96f
3 Jul 19
Regulation FD Disclosure
6:58am
8-K
EX-99.1
333n3onh725jit v1
2 Jul 19
Neuronetics Appoints Stephen Furlong as Chief Financial Officer
5:17pm
8-K
EX-10.1
y6tp0d8r
2 Jul 19
Neuronetics Appoints Stephen Furlong as Chief Financial Officer
5:17pm
8-K
EX-99.1
arnyqw8guxptic
7 May 19
Neuronetics Reports First Quarter 2019 Financial and Operating Results
7:31am
DEF 14A
aeraey1i 5bk7
12 Apr 19
Definitive proxy
5:05pm
PRE 14A
ubmjx0e nx6
2 Apr 19
Preliminary proxy
5:15pm
8-K
EX-99.1
3mw0m ou6du
27 Mar 19
NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan
5:29pm
8-K
EX-99.1
a4va q1jep
5 Mar 19
Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
7:00am
10-K
91nmgdp9p
5 Mar 19
Annual report
12:00am
8-K
EX-99.1
7gfj nszjv5fzjexthf
15 Feb 19
Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors
8:05am
8-K
EX-99.1
lhi 8hw80tvok
7 Jan 19
Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
8:00am
8-K
EX-99.1
5xqc 5h30wk6fkip
6 Nov 18
Neuronetics Reports Third Quarter 2018 Financial and Operating Results
7:02am
8-K
EX-99.1
qdoyn
14 Aug 18
Neuronetics Reports Second Quarter 2018 Financial and Operating Results
7:00am
S-8
n5ql9 nkxnhfmk
26 Jul 18
Registration of securities for employees
12:00am
424B4
9m7lf
29 Jun 18
Prospectus supplement with pricing info
4:02pm